Drug—target network
暂无分享,去创建一个
[1] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[2] K. Johnson. An Update. , 1984, Journal of food protection.
[3] G. Scangos,et al. Drug discovery in the postgenomic era , 1997, Nature Biotechnology.
[4] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[5] A. Barabasi,et al. Lethality and centrality in protein networks , 2001, Nature.
[6] D. Fell,et al. The small world inside large metabolic networks , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[7] Leena Peltonen,et al. Dissecting Human Disease in the Postgenomic Era , 2001, Science.
[8] David Valle,et al. Human disease genes , 2001, Nature.
[9] M E Newman,et al. Scientific collaboration networks. I. Network construction and fundamental results. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.
[10] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[11] Nicola J. Rinaldi,et al. Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.
[12] K. Lindpaintner. The impact of pharmacogenetics and pharmacogenomics on drug discovery , 2002, Nature Reviews Drug Discovery.
[13] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[14] Alex Matter,et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.
[15] J. Drews. Stategic trends in the drug industry. , 2003, Drug discovery today.
[16] Leland J. Gershell,et al. A brief history of novel drug discovery technologies , 2003, Nature Reviews Drug Discovery.
[17] Sumit K Chanda,et al. Fulfilling the promise: drug discovery in the post-genomic era. , 2003, Drug discovery today.
[18] D. Searls. Pharmacophylogenomics: genes, evolution and drug targets , 2003, Nature Reviews Drug Discovery.
[19] M. Gerstein,et al. Structure and evolution of transcriptional regulatory networks. , 2004, Current opinion in structural biology.
[20] E. Kunkel. Systems biology in drug discovery , 2004, Nature Biotechnology.
[21] B. Roth,et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.
[22] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[23] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[24] Lan V. Zhang,et al. Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.
[25] Andrey Rzhetsky,et al. Emergent behavior of growing knowledge about molecular interactions , 2005, Nature Biotechnology.
[26] J. Greef,et al. Rescuing drug discovery: in vivo systems pathology and systems pharmacology , 2005, Nature Reviews Drug Discovery.
[27] Simon K. Mencher,et al. Promiscuous drugs compared to selective drugs (promiscuity can be a virtue) , 2005, BMC clinical pharmacology.
[28] H. Lehrach,et al. A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.
[29] S. Lampel,et al. The druggable genome: an update. , 2005, Drug discovery today.
[30] Ricard V Solé,et al. Topology, tinkering and evolution of the human transcription factor network , 2005, The FEBS journal.
[31] Marc Vidal,et al. Interactome modeling , 2005, FEBS letters.
[32] H. Aburatani,et al. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. , 2005, Genomics.
[33] Judith A. Blake,et al. The Mouse Genome Database (MGD): from genes to mice—a community resource for mouse biology , 2004, Nucleic Acids Res..
[34] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[35] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[36] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[37] Celerino Abad-Zapatero,et al. Faculty Opinions recommendation of DrugBank: a comprehensive resource for in silico drug discovery and exploration. , 2006 .
[38] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[39] Neda Nategh,et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network , 2006 .
[40] P. Imming,et al. Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.
[41] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[42] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.